Shares of R1 RCM Inc (NASDAQ:RCM) have received an average recommendation of “Buy” from the seven brokerages that are covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $10.00.
RCM has been the topic of several research analyst reports. Zacks Investment Research raised shares of R1 RCM from a “strong sell” rating to a “hold” rating in a research note on Wednesday, July 18th. Cantor Fitzgerald restated a “buy” rating and issued a $10.00 price objective on shares of R1 RCM in a report on Friday, July 27th. BidaskClub lowered shares of R1 RCM from a “buy” rating to a “hold” rating in a report on Tuesday, July 3rd. TheStreet lowered shares of R1 RCM from a “c” rating to a “d+” rating in a report on Wednesday, May 9th. Finally, ValuEngine upgraded shares of R1 RCM from a “buy” rating to a “strong-buy” rating in a report on Wednesday, May 2nd.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Cubist Systematic Strategies LLC acquired a new position in R1 RCM in the first quarter valued at approximately $100,000. GSA Capital Partners LLP acquired a new position in R1 RCM in the second quarter valued at approximately $122,000. Teacher Retirement System of Texas acquired a new position in R1 RCM in the second quarter valued at approximately $147,000. Allianz Asset Management GmbH acquired a new position in R1 RCM in the first quarter valued at approximately $148,000. Finally, Trexquant Investment LP acquired a new position in R1 RCM in the first quarter valued at approximately $156,000. Institutional investors and hedge funds own 49.21% of the company’s stock.
R1 RCM (NASDAQ:RCM) last released its quarterly earnings results on Thursday, August 9th. The financial services provider reported ($0.07) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.05) by ($0.02). R1 RCM had a negative net margin of 11.31% and a negative return on equity of 46.55%. The company had revenue of $207.90 million for the quarter, compared to the consensus estimate of $200.59 million. R1 RCM’s quarterly revenue was up 109.2% compared to the same quarter last year. sell-side analysts anticipate that R1 RCM will post -0.17 EPS for the current fiscal year.
R1 RCM Company Profile
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.
Recommended Story: How to Invest in Marijuana Stocks
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.